Swedish Orphan Biovitrum AB

SOBI: XSTO (SWE)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
ChrLOCK|>!%>LOCK|qp%$dxP

Sobi Earnings: Strong Demand for Strategic Portfolio Drives Sales Growth; Positive Outlook

Swedish Orphan Biovitrum reported second-quarter results, highlighted by 13% year-over-year growth. Its strategic portfolio accounted for 55% of revenue in the quarter. Management's underlying business outlook is unchanged.

Sponsor Center